Claude discovers CRISPR-like ART enzyme system
Anthropic announced that Claude discovered a new enzyme system in phage DNA named ART (Array-associated Reverse Transcriptase), structurally similar to CRISPR. The discovery was made by ~950 Claude agents working 21 hours, consuming 210 million tokens. Experts consider it a potential new gene editing mechanism.
Key insights
Claude independently identified the ART system through genomic mining
Anthropic's life sciences team gave Claude a broad prompt to find novel reverse transcriptases in DNA databases. About 950 Claude agents ran for 21 hours, screening over 200,000 reverse transcriptases, narrowing to 3,500 candidates and then 20 top ones. One agent recognized the repeat array, counted repeats, measured spacing, and compared with known systems before submitting to humans. The array and partner protein were first discovered by Claude.
ART system may enable new gene editing tools
ART consists of a reverse transcriptase, a partner gene with unknown function, and evenly spaced repeat DNA sequences, similar to CRISPR arrays. Early experiments confirm the array transcribes into distinct short RNAs, suggesting programmable mechanisms. Only a few similar systems are known, all capable of cutting, copying, or pasting DNA. CRISPR pioneer Feng Zhang praised the discovery.
Anthropic CEO sees AI-driven biology discovery on an exponential trend
Dario Amodei compared AI progress in biology to math: math competitions from weak to top solutions in a few years. He believes AI for biology is on a similar exponential trajectory, though wet-lab experimentation remains necessary. He envisions AI eventually controlling lab equipment safely. The team's wet lab performs BSL-1/BSL-2 work.